Cannabis Operator Nixes Deal, Fires CFO
MedMen is opting out of a transaction with Pharmacann as it increases its focus on profitability, says CEO Adam Bierman.
Antitrust Review: Navigating the Challenges of a ‘Second Request’
When an M&A transaction is flagged for a deeper regulatory review, the buyer and seller may be faced with significant challenges.
Third Point Fined Over Antitrust Violations
The activist fund allegedly failed to comply with premerger notification rules before acquiring stock in DowDuPont two years ago.
Canon, Toshiba Fined Over Antitrust Violations
The companies allegedly structured a deal so it would not be delayed by U.S. pre-merger notification laws.
Activist Fund Fined $11M on Antitrust Charges
ValueAct failed to notify regulators that it purchased stock in Baker Hughes and Halliburton after the two companies proposed a merger, says the DOJ.